Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03188731Completed

ZIKAlliance Pregnant Women Cohort

Role: collaborator

NCT04345133Not ApplicableCompleted

Effect of Undersized Drilling Upon the Immediate Implants

Role: lead

NCT01228214Phase 2Unknown

Novel Treatment for Coronary Artery Disease

Role: lead

NCT01231165Phase 2Completed

Treatment of Coronary Heart Disease With Amiloride

Role: lead

All 4 trials loaded